Cambridge, MA, United States of America

Celeste Richardson

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 10.9

ph-index = 3

Forward Citations = 111(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Celeste Richardson: Innovator in Cancer Treatment

Introduction

Celeste Richardson, a prominent inventor based in Cambridge, MA, has made significant contributions to the field of cancer treatment. With a total of seven patents under her name, she has focused on developing advanced therapies that target specific cancer-related antigens.

Latest Patents

One of Richardson's notable inventions is a method for treating cancer using a CD33 chimeric antigen receptor. This invention encompasses compositions and methods aimed at treating diseases associated with the expression of CD33. It also includes innovative chimeric antigen receptors (CAR) specific to CD33, vectors encoding these receptors, and recombinant T cells comprising the CD33 CAR. Furthermore, her work outlines methods for administering genetically modified T cells that express a CAR with a CD33 binding domain.

In addition, she has developed a treatment involving a humanized anti-BCMA chimeric antigen receptor. This invention provides compositions and methods for addressing diseases associated with the expression of BCMA. Similar to her previous work, it includes CARs specific to BCMA, vectors encoding them, and recombinant T cells incorporating the BCMA CAR. She also details methods for administering genetically modified T cells expressing a CAR that has a BCMA binding domain.

Career Highlights

Celeste Richardson has worked with leading organizations in the field of biomedical research, including Novartis and the University of Pennsylvania. Her career is marked by groundbreaking work that has the potential to revolutionize cancer therapies.

Collaborations

Throughout her career, Richardson has collaborated with notable coworkers such as Hilmar Erhard Ebersbach and Reshma Singh. These partnerships have helped expand the scope of her research and enhance the development of her innovative therapies.

Conclusion

Celeste Richardson's contributions to cancer treatment through her inventive work in chimeric antigen receptors underscore her position as a key figure in the ongoing battle against cancer. With her seven patents, she continues to pave the way for new and effective treatments that hold promise for many patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…